activins has been researched along with Multiple Sclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banos, A; Belaidi, E; Doskas, T; Garbis, SD; Kalamatas, T; Kapasa, M; Karageorgiou, K; Konstantopoulos, D; Lomenick, B; Manousopoulou, A; Morianos, I; Pan, F; Papadopoulou, G; Quintana, FJ; Sallusto, F; Semitekolou, M; Trochoutsou, AI; Wei, P; Xanthou, G | 1 |
| Bi, Y; Guo, Z; Li, JL; Li, P; Markovic-Plese, S; Seyedsadr, M; Wan, YY; Wu, B; Xu, X; Zhang, S; Zhou, M | 1 |
| Aladro, Y; Álvarez-Cermeño, JC; Álvarez-Lafuente, R; Comabella, M; Costa-Frossard, L; Domínguez-Mozo, MI; Espejo, C; Espiño, M; Fernández-Velasco, JI; Guaza, C; Masjuan, J; Matute-Blanch, C; Medina, S; Monreal, E; Muñoz-San Martín, M; Muriel, A; Picón, C; Quintana, E; Ramió-Torrentà, L; Rodríguez-Martín, E; Roldán, E; Sainz de la Maza, S; Tejeda-Velarde, A; Villar, LM; Villarrubia, N | 1 |
| Boĭko, AN; Demina, TL; Gusev, EI; Popova, NF; Stepanenko, RN | 1 |
| Cheknev, SB; Denisov, LA; Ershov, FI; Latysheva, OL | 1 |
| Borisova, AM; Glazko, AV; Petrov, RV; Simonova, AV; Stepanenko, RN | 1 |
1 trial(s) available for activins and Multiple Sclerosis
| Article | Year |
|---|---|
[Results of clinico-immunological testing of myelopid in chronic forms of multiple sclerosis].
Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Double-Blind Method; Drug Administration Schedule; Female; Humans; In Vitro Techniques; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Placebos; T-Lymphocytes; T-Lymphocytes, Regulatory | 1992 |
5 other study(ies) available for activins and Multiple Sclerosis
| Article | Year |
|---|---|
Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
Topics: 5'-Nucleotidase; Activins; Animals; Antigens, CD; Apyrase; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; GPI-Linked Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Th17 Cells | 2020 |
The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
Topics: Activin Receptors, Type I; Activins; Animals; Cell Differentiation; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Humans; Mice; Mice, Knockout; Molecular Targeted Therapy; Multiple Sclerosis; Neurogenic Inflammation; Signal Transduction; Th17 Cells; Transforming Growth Factor beta | 2021 |
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis.
Topics: Activins; Adolescent; Adult; Aged; Antibodies, Viral; B-Lymphocytes; B7-H1 Antigen; Biomarkers; Chitinase-3-Like Protein 1; Female; Humans; Immunosenescence; Linear Models; Male; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Oligoclonal Bands; T-Lymphocytes; Young Adult | 2021 |
[Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Drug Combinations; Drug Interactions; Enkephalin, Leucine-2-Alanine; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Killer Cells, Natural; Multiple Sclerosis; Oligopeptides; Peptides; Recombinant Proteins; Thymus Extracts | 1992 |
[Efficacy of myelopid in immunodeficiency states].
Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes | 1990 |